85 related articles for article (PubMed ID: 16099788)
1. Silencing RNA: a novel treatment for pancreatic cancer?
Lemoine NR
Gut; 2005 Sep; 54(9):1215-6. PubMed ID: 16099788
[No Abstract] [Full Text] [Related]
2. MUC1 Knockdown With RNA Interference Inhibits Pancreatic Cancer Growth.
Yuan Z; Liu X; Wong S; Machan JT; Chung MA
J Surg Res; 2009 Nov; 157(1):e39-46. PubMed ID: 19482310
[TBL] [Abstract][Full Text] [Related]
3. [Experimental study of MAT1 gene silencing mediated by siRNA in pancreatic cancer].
Liu JP; Yuan SZ; Zhang SN
Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(38):2719-23. PubMed ID: 18167254
[TBL] [Abstract][Full Text] [Related]
4. Materializing the potential of small interfering RNA via a tumor-targeting nanodelivery system.
Pirollo KF; Rait A; Zhou Q; Hwang SH; Dagata JA; Zon G; Hogrefe RI; Palchik G; Chang EH
Cancer Res; 2007 Apr; 67(7):2938-43. PubMed ID: 17409398
[TBL] [Abstract][Full Text] [Related]
5. Lentivirus-mediated short hairpin RNA targeting the APRIL gene suppresses the growth of pancreatic cancer cells in vitro and in vivo.
Wang F; Chen L; Mao ZB; Shao JG; Tan C; Huang WD
Oncol Rep; 2008 Jul; 20(1):135-9. PubMed ID: 18575728
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic potential of RNA interference against cancer.
Takeshita F; Ochiya T
Cancer Sci; 2006 Aug; 97(8):689-96. PubMed ID: 16863503
[TBL] [Abstract][Full Text] [Related]
7. Targeting XIAP bypasses Bcl-2-mediated resistance to TRAIL and cooperates with TRAIL to suppress pancreatic cancer growth in vitro and in vivo.
Vogler M; Walczak H; Stadel D; Haas TL; Genze F; Jovanovic M; Gschwend JE; Simmet T; Debatin KM; Fulda S
Cancer Res; 2008 Oct; 68(19):7956-65. PubMed ID: 18829553
[TBL] [Abstract][Full Text] [Related]
8. Downregulation of survivin by siRNA diminishes radioresistance of pancreatic cancer cells.
Kami K; Doi R; Koizumi M; Toyoda E; Mori T; Ito D; Kawaguchi Y; Fujimoto K; Wada M; Miyatake S; Imamura M
Surgery; 2005 Aug; 138(2):299-305. PubMed ID: 16153440
[TBL] [Abstract][Full Text] [Related]
9. Efficient electrogene therapy for pancreatic adenocarcinoma treatment using the bacterial purine nucleoside phosphorylase suicide gene with fludarabine.
Deharvengt S; Rejiba S; Wack S; Aprahamian M; Hajri A
Int J Oncol; 2007 Jun; 30(6):1397-406. PubMed ID: 17487360
[TBL] [Abstract][Full Text] [Related]
10. All in the RNA family.
Davidson BL
Nat Biotechnol; 2006 Aug; 24(8):951-2. PubMed ID: 16900139
[No Abstract] [Full Text] [Related]
11. Introduction of a survivin gene-specific small inhibitory RNA inhibits growth of pancreatic cancer cells.
Tsuji N; Asanuma K; Kobayashi D; Yagihashi A; Watanabe N
Anticancer Res; 2005; 25(6B):3967-72. PubMed ID: 16309185
[TBL] [Abstract][Full Text] [Related]
12. RNA interference in the mouse vascular endothelium by systemic administration of siRNA-lipoplexes for cancer therapy.
Santel A; Aleku M; Keil O; Endruschat J; Esche V; Durieux B; Löffler K; Fechtner M; Röhl T; Fisch G; Dames S; Arnold W; Giese K; Klippel A; Kaufmann J
Gene Ther; 2006 Sep; 13(18):1360-70. PubMed ID: 16625242
[TBL] [Abstract][Full Text] [Related]
13. Advances in the development of siRNA-based therapeutics for cancer.
Shen Y
IDrugs; 2008 Aug; 11(8):572-8. PubMed ID: 18683092
[TBL] [Abstract][Full Text] [Related]
14. Prolonged gene silencing in hepatoma cells and primary hepatocytes after small interfering RNA delivery with biodegradable poly(beta-amino esters).
Vandenbroucke RE; De Geest BG; Bonné S; Vinken M; Van Haecke T; Heimberg H; Wagner E; Rogiers V; De Smedt SC; Demeester J; Sanders NN
J Gene Med; 2008 Jul; 10(7):783-94. PubMed ID: 18470950
[TBL] [Abstract][Full Text] [Related]
15. Antitumor activity of an oncolytic adenovirus-delivered oncogene small interfering RNA.
Zhang YA; Nemunaitis J; Samuel SK; Chen P; Shen Y; Tong AW
Cancer Res; 2006 Oct; 66(19):9736-43. PubMed ID: 17018633
[TBL] [Abstract][Full Text] [Related]
16. Polymer-based siRNA delivery: perspectives on the fundamental and phenomenological distinctions from polymer-based DNA delivery.
Gary DJ; Puri N; Won YY
J Control Release; 2007 Aug; 121(1-2):64-73. PubMed ID: 17588702
[TBL] [Abstract][Full Text] [Related]
17. Retinoic acid receptor antagonists inhibit miR-10a expression and block metastatic behavior of pancreatic cancer.
Weiss FU; Marques IJ; Woltering JM; Vlecken DH; Aghdassi A; Partecke LI; Heidecke CD; Lerch MM; Bagowski CP
Gastroenterology; 2009 Dec; 137(6):2136-45.e1-7. PubMed ID: 19747919
[TBL] [Abstract][Full Text] [Related]
18. Tissue-specific shRNA delivery: a novel approach for gene therapy in cancer.
Ghatak S; Hascall VC; Berger FG; Penas MM; Davis C; Jabari E; He X; Norris JS; Dang Y; Markwald RR; Misra S
Connect Tissue Res; 2008; 49(3):265-9. PubMed ID: 18661357
[TBL] [Abstract][Full Text] [Related]
19. Genetic adjuvant therapy for pancreatic cancer and other solid tumours.
Bagley KC
Gut; 2008 Mar; 57(3):289-91. PubMed ID: 18268052
[No Abstract] [Full Text] [Related]
20. Short hairpin RNA-expressing oncolytic adenovirus-mediated inhibition of IL-8: effects on antiangiogenesis and tumor growth inhibition.
Yoo JY; Kim JH; Kim J; Huang JH; Zhang SN; Kang YA; Kim H; Yun CO
Gene Ther; 2008 May; 15(9):635-51. PubMed ID: 18273054
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
